| Profile | GDS4177 / 202735_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 124.12 | 73 |
| GSM603099 | KU-812 non-treated | 155.48 | 76 |
| GSM603098 | KCL-22 Imatinib-treated | 348.67 | 86 |
| GSM603097 | KCL-22 non-treated | 494.81 | 89 |
| GSM603102 | JURL-MK1 Imatinib-treated | 268.32 | 83 |
| GSM603101 | JURL-MK1 non-treated | 335.21 | 86 |